These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the NRXN1 gene in a Chinese autism cohort. Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623 [TBL] [Abstract][Full Text] [Related]
5. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population. Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380 [TBL] [Abstract][Full Text] [Related]
6. Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. Mühleisen TW; Basmanav FB; Forstner AJ; Mattheisen M; Priebe L; Herms S; Breuer R; Moebus S; Nenadic I; Sauer H; Mössner R; Maier W; Rujescu D; Ludwig M; Rietschel M; Nöthen MM; Cichon S Schizophr Res; 2011 Apr; 127(1-3):35-40. PubMed ID: 21288692 [TBL] [Abstract][Full Text] [Related]
7. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627 [TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of 17 NRXN1 deletions. Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137 [TBL] [Abstract][Full Text] [Related]
9. Association study between the neurexin-1 gene and tardive dyskinesia. Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489 [TBL] [Abstract][Full Text] [Related]
10. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility. Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950 [TBL] [Abstract][Full Text] [Related]
14. CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. Nag A; Bochukova EG; Kremeyer B; Campbell DD; Muller H; Valencia-Duarte AV; Cardona J; Rivas IC; Mesa SC; Cuartas M; Garcia J; Bedoya G; Cornejo W; Herrera LD; Romero R; Fournier E; Reus VI; Lowe TL; Farooqi IS; ; Mathews CA; McGrath LM; Yu D; Cook E; Wang K; Scharf JM; Pauls DL; Freimer NB; Plagnol V; Ruiz-Linares A PLoS One; 2013; 8(3):e59061. PubMed ID: 23533600 [TBL] [Abstract][Full Text] [Related]
15. Mini-review: Update on the genetics of schizophrenia. Coelewij L; Curtis D Ann Hum Genet; 2018 Sep; 82(5):239-243. PubMed ID: 29923609 [TBL] [Abstract][Full Text] [Related]
17. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia. Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984 [TBL] [Abstract][Full Text] [Related]
19. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]